301211.SZ · 亨迪药业
China A-shares · RS rating 87 · As of 2026-10-14
| Price | 12.04 CNY |
|---|---|
| 1-day change | -2.4% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 83 / 71 / 69 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 35 / 37 / 30 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +6.0% |
| Distance from 52-week high | +24.9% |
| Market cap (USD) | $796.3M |